English
Title99mTechnetium Labeled Compounds
SubtitleProceedings of the 7th Annual Meeting of the Japanese Society of Nuclear Medicine XIII. Invited Lectures by the Foreign Lecturers
AuthorsP. RICHARDS, H. L. ATKINS
Authors(kana)
OrganizationNuclear Engineering Department, Medical Research Department Brookhaven National Laboratory Upton
JournalThe Japanese Journal of nuclear medicine
Volume5
Number3
Page165-170
Year/Month1968/10
ArticleReport
PublisherTHE JAPANESE SOCIETY OF NUCLEAR MEDICINE
Abstract[Summary] The radionuclide 99mTc has played an important role in the rapid growth of nuclear medciine due to its combination of excellent physical characteristics and its ready availability from the 99Mo-99mTc generator, The development of compounds labeled with 99mTc having different biological distributions has greatly increased its usefulness and made it the nuclide of choice for several applications. A detailed study of the chemistry invovled in labeling human serum albumin with technetium has resulted in the development of a reproducible method for labeling with high efficiency and the production of a product of high specific activity. As a result of these studies a new compound, 99mTc-DTPA, has been prepared which may further enhance the usefulness of the nuclide in nuclear medicine. The authors are indebted to Mr. James Baranosky for technical assistance in these studies.
PracticeClinical medicine
Keywords

ySPDFz